Eugene Sun - Articles and news items

Abbott logo

FDA approve two three-month strengths of Lupron Depot-PED® (leuprolide acetate for depot suspension)

Industry news, News / 16 August 2011 / Abbott

Two strengths for three-month administration of Lupron Depot-PED ® approved…

Abbott logo

Biogen Idec and Abbott announce positive top-line results

Industry news, News / 9 August 2011 / Abbott

Biogen Idec and Abbott announced positive top-line results from SELECT, a global, registrational Phase 2b clinical trial…

Abbott logo

Abbott receives FDA approval for a new six-month formulation of Lupron Depot®

Industry news, News / 20 June 2011 / Abbott

“Lupron Depot is an important treatment option for many patients…”

Abbott logo

Abbott receives FDA approval for CREON® (pancrelipase) infant-specific dosage

Industry news, News / 14 June 2011 / Abbott

The U.S. FDA approved an infant-specific dose of CREON® (pancrelipase) Delayed-Release Capsules to treat EPI due to cystic fibrosis…

Abbott logo


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...